PGRN Hub
  • Home
  • What is PGRN?
  • Members
    • Join
    • Members >
      • Member Research Interests
      • Members List
      • Members Directory
    • Apply for a Webpage
    • Research Pages >
      • African American Pharmacogenomics
      • Clinical Implementation of PGx
      • I-PICC: Integrating Pharmacogenetics in Clinical Care
      • Genetics of Israeli Populations (NLGIP)
      • GeT-RM PGx
      • Metformin PGx
      • MT-targeting agents
      • PEGASUS: Personalizing Emergency/Acute Therapeutics Utilizing Systems Biology
      • PGx of AIWG
      • PGx of Chemotherapeutic Toxicities
      • PGx of Statin Therapy
      • Precision Medicine In Leukemia
      • Predicting Drug Action
      • ...More Pages Coming Soon
    • Partner PGx Organizations >
      • UKPSMN
      • UPGx
    • Communities >
      • MetGen
    • Leadership
  • Data & Tools
    • GWAS Statistics >
      • RIKEN GWAS Statistics
    • Tools
  • PGRN Resources
    • Clinical Implementation
    • Functional Pharmacogenes
    • PGRN Hub
    • PGRN-PiLS Resource
    • PGRN-RIKEN >
      • RIKEN Publications
      • RIKEN Investigators
      • RIKEN Projects
    • PharmGKB
    • PharmVar
    • RPGEH
  • News
    • Event Calendar
    • PGX News
    • Featured Investigators
    • PGRN Recorded Talks
    • All PGRN Publications
  • Meetings
    • Monthly Member RIPS
    • All-Members Calls
    • Upcoming PGRN Meetings >
      • Poster Session at ASCPT 2019
      • CPIC® Meeting 2019
    • Past PGRN Meetings >
      • ASHG 2018
      • ASHG 2017
      • CPIC® Meeting 2017
      • ASHG 2016
      • Annual PGRN meeting at ASCPT 2016
      • 2015 PGRN All PIs Retreat
    • Other PGx Meetings

PGx News

A comprehensive surveillance of 120 pharmacogenes in 26 populations

10/28/2016

 
By analyzing the available 1000 Genomes Project Phase 3 data, Wright G. et al. reported findings for 120 pharmacogenes variations in 26 world populations in this recent published paper. Some of the highlights from the analyses include the following. 

Number of missense variants per coding sequence length ranges from 0.001 (YEATS4) to 0.058 (IFNL3).

The most conserved pharmacogenes include those genes where somatic mutations are biomarker for selecting cancer treatment for patients (e.g. BRAF, KRAS) or genes associated for disease or drug targets (e.g. HMGCR, ADRB1).

There are 23 pharmacogenes that contained highly differentiated pharmacogenomics variants across the different ethnic populations (e.g. ABCG2, ADH1B, IFNL3) and 17 pharmacogenes, which have rare variant (MAF <0.5%) that was common in one population (e.g. ACE, CYP2C19, CYP2B6, CYP2C8, GSTT1).

97% of the individual in the 1000 Genomes Project carried a high evidence clinical variant.  The European populations had the highest mean number of clinical variants (4.1) whereas the African populations had the lowest number of such variants (2.3).

90% of the variation was made up of the rare variants and singletons and the relative frequency of loss-of-function variants is inversely correlated with allele frequency. 
​
It is worth reading what other variations were described in this paper that could be relevant to your pharmacogenomics research.  Notably, the code that was used to perform the various analyses is available.  Feel free to provide your comment below if there are highlights that are worth mentioning from this papers.

Spotlight of the PGRN-ASHG Symposium

10/26/2016

 
This is the first joint meeting of the Pharmacogenomics Research Network (PGRN) and the American Society of Human Genetics (ASHG).  We were thrilled with the great turn out. The Symposium brought together scientists from different areas of human genetics and pharmacogenomics!  Special thanks to our speakers, poster participants and twitters followers. We also thank you for your participation in the Q&As and for sharing your ideas and expertise through out the symposium. We found all the presentations engaging and enlightening, but would like to particularly thank the panelists for a stimulating discussion on the issues relevant to implementation of pharmacogenomic testing.  We also thank the organizers and speakers of the final session focused on the evolution of pharmacogenes.  To our knowledge this was a first session of its kind and represents a great example of potential interactions between scientists in pharmacogenomics and those in population genetics. Your feedback and comments on all our sessions are our top priorities.  Finally, we promise you that the videos of recorded talks will be posted here soon!   
The PGRN-Hub Team

Poster Award Winners

10/18/2016

 
The PGRN Hub congratulates 5 Poster Award Winners and the other poster presenters who described their recent work at the 2016 PGRN-ASHG Symposium– The Expanding Universe of Pharmacogenomics. 

Trainee Abstract Award Winners

Katrina Claw
UNIVERSITY OF WASHINGTON
"Genetic & transcriptomic variation in human hepatic pharmacogenes"
Sang Won Lee
SEOUL NATIONAL UNIVERSITY HOSPITAL
​
"Effect of SULTB1, CHST3, & SLC15A1 genotypes on pharmacokinetics of YH4808 in human"
Soo Min Han
YONSEI UNIVERSITY COLLEGE OF MEDICINE
"Targeted next generation sequencing for genomic analysis of variable drug response"

Best Poster Award Winners

Amy Turner
MEDICAL COLLEGE OF WISCONSIN
"Implementation of Affymetrix PharmacoScan for comprehensie preemptive clinical pharmacogenetics testing"
Dione Bailey, Jason Ross, Don Skifter, Josiah Allen, & Aaron Solomon
ONEOME
"Best practices for pharmacogenomics test implementation & integrating the OneOme RightMed test into clinical practice"

Whole genome sequencing is more effective interrogating variants in pharmacogenes

10/6/2016

 
In this October issue of Clinical Pharmacology & Therapeutics, Yang et al. highlighted several important variants in pharmacogenes that could be missed if whole exome sequencing or genotyping array was used instead of whole genome sequencing.  Among the thirteen CPIC® important genes, missing important variants are found in CYP2D6, CYP3A5, DPYD, G6PD, IFNL3, VKORC1 if whole genome sequencing were not used.

    Author

    The Hub team

    Archives

    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    April 2016
    March 2016
    December 2015
    October 2015
    September 2015

    Categories

    All
    Funding Opportunities
    Meeting News
    Meetings
    PGRN Supported Meetings

    RSS Feed

Join

Contact Us

Feedback

Picture
  • Home
  • What is PGRN?
  • Members
    • Join
    • Members >
      • Member Research Interests
      • Members List
      • Members Directory
    • Apply for a Webpage
    • Research Pages >
      • African American Pharmacogenomics
      • Clinical Implementation of PGx
      • I-PICC: Integrating Pharmacogenetics in Clinical Care
      • Genetics of Israeli Populations (NLGIP)
      • GeT-RM PGx
      • Metformin PGx
      • MT-targeting agents
      • PEGASUS: Personalizing Emergency/Acute Therapeutics Utilizing Systems Biology
      • PGx of AIWG
      • PGx of Chemotherapeutic Toxicities
      • PGx of Statin Therapy
      • Precision Medicine In Leukemia
      • Predicting Drug Action
      • ...More Pages Coming Soon
    • Partner PGx Organizations >
      • UKPSMN
      • UPGx
    • Communities >
      • MetGen
    • Leadership
  • Data & Tools
    • GWAS Statistics >
      • RIKEN GWAS Statistics
    • Tools
  • PGRN Resources
    • Clinical Implementation
    • Functional Pharmacogenes
    • PGRN Hub
    • PGRN-PiLS Resource
    • PGRN-RIKEN >
      • RIKEN Publications
      • RIKEN Investigators
      • RIKEN Projects
    • PharmGKB
    • PharmVar
    • RPGEH
  • News
    • Event Calendar
    • PGX News
    • Featured Investigators
    • PGRN Recorded Talks
    • All PGRN Publications
  • Meetings
    • Monthly Member RIPS
    • All-Members Calls
    • Upcoming PGRN Meetings >
      • Poster Session at ASCPT 2019
      • CPIC® Meeting 2019
    • Past PGRN Meetings >
      • ASHG 2018
      • ASHG 2017
      • CPIC® Meeting 2017
      • ASHG 2016
      • Annual PGRN meeting at ASCPT 2016
      • 2015 PGRN All PIs Retreat
    • Other PGx Meetings